Humanised anti-mag antibody or functional fragment thereof
US7612183B2 · kind B2 · utility
15Cited by
7References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 2003 |
| Grant date | Nov 3, 2009 |
| Priority date | — |
| Expiry date | Apr 5, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to altered antibodies to myelin associated glycoprotein (MAG), pharmaceutical formulations containing them and to the use of such antibodies in the treatment and/or prophylaxis of neurological diseases/disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.